Huff James Warren

CIK 00016624111 companyIRVING, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001662411

Recent Transactions

50 trades

Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−146,824→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−20,133→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−28,625→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−99,950→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−28,625→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−23,968→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−275,436→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−10,398→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class B common stock
2023-09-26−212,903→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−51,818→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−124,600→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−57,250→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−122,480→ 0 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right-to-buy)
2023-07-06+275,436→ 275,436 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-06+11,656→ 49,916 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-06+72,564→ 122,480 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$88.59/sh−12,826→ 47,093 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$87.61/sh−4,034→ 59,919 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$89.49/sh−5,742→ 41,351 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$90.57/sh−4,623→ 36,728 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$91.12/sh−570→ 36,158 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$81.49/sh−8,104→ 103,054 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$83.31/sh−9,660→ 81,262 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$84.33/sh−7,439→ 73,823 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$85.25/sh−6,395→ 67,428 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$86.44/sh−3,475→ 63,953 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$82.20/sh−12,132→ 90,922 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-03-01−75,000→ 212,903 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-01+75,000→ 111,158 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right-to-buy)
2023-01-03+190,950→ 190,950 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-01-03+47,025→ 47,025 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2021-01-04+44,600→ 44,600 total
Gift
REATA PHARMACEUTICALS INC
Class B common stock
2020-12-22−67,500→ 575,806 total
Gift
REATA PHARMACEUTICALS INC
Class B common stock
2020-12-22−67,500→ 575,806 total
Gift
REATA PHARMACEUTICALS INC
Class B common stock
2020-12-22+67,500→ 0 total
Gift
REATA PHARMACEUTICALS INC
Class B common stock
2020-12-22−67,500→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2020-11-10$175.00/sh−64,970→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2020-11-09$175.06/sh−16,687→ 64,970 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2020-01-02+40,000→ 40,000 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-11-11+57,250→ 57,250 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-10-14+57,250→ 57,250 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-09-27$86.61/sh−63,000→ 94,157 total
Gift
REATA PHARMACEUTICALS INC
Class A common stock
2019-09-23−12,500→ 164,157 total
Gift
REATA PHARMACEUTICALS INC
Class A common stock
2019-09-23+12,500→ 12,500 total
Gift
REATA PHARMACEUTICALS INC
Class A common stock
2019-09-23−7,000→ 157,157 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-01-02+114,500→ 114,500 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2017-12-12$11.00/sh+10,000→ 710,806 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2017-12-12−10,000→ 103,636 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2017-12-06+249,200→ 249,200 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2016-12-07+199,900→ 199,900 total

Companies

REATA PHARMACEUTICALS INC
Director, See Remarks

Recent Filings

Address

2801 GATEWAY DRIVE, SUITE 150

IRVING, TX, 75063

View on SEC.gov